Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	No Par, Preferred Stock	No Par, Common Stock	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period at Dec. 31, 2022	$ 18,950		$ 97,913	$ (60,760)	$ (18,203)
Balance at beginning of period (in shares) at Dec. 31, 2022			12,215,849
Net income (loss)	1,001			1,001
Stock-based compensation expense	55		$ 55
Other comprehensive income (loss)	2,286				2,286
Balance at end of period at Mar. 31, 2023	22,292		$ 97,968	(59,759)	(15,917)
Balance at ending of period (in shares) at Mar. 31, 2023			12,215,849
Balance at beginning of period at Dec. 31, 2023	2,889	$ 6,000	$ 98,100	(86,683)	(14,528)
Balance at beginning of period (in shares) at Dec. 31, 2023		1,000	12,222,881
Net income (loss)	231			231
Stock-based compensation expense	32		$ 32
Cash dividends paid on preferred stock	(157)			(157)
Other comprehensive income (loss)	(436)				(436)
Balance at end of period at Mar. 31, 2024	$ 2,559	$ 6,000	$ 98,132	$ (86,609)	$ (14,964)
Balance at ending of period (in shares) at Mar. 31, 2024		1,000	12,222,881